j
u
r
n
l
p
r
e
p
r
f
choos
cyclosporin
firstlin
therapi
pneumonia
elegir
ciclosporina
como
primera
para
la
causada
por
sir
use
immunosuppress
therapi
infect
recent
rais
topic
come
fill
unmet
need
manag
patient
intriguingli
also
sar
mer
cov
member
betacoronaviru
genu
associ
increas
risk
respiratori
distress
syndrom
alreadi
patient
sarscov
develop
respiratori
failur
thought
consequ
vigor
innat
immun
respons
effect
tocilizumab
infect
patient
also
support
particip
cytokin
storm
sever
phenotyp
factor
underli
explos
respons
could
capac
betacoronavirus
invad
immunecompet
cell
particularli
macrophag
therebi
hijack
major
driver
innat
immun
respons
nonetheless
target
proinflammatori
cytokin
neither
sole
firstlin
immunomodulatori
approach
combat
infect
repres
figur
complex
virushost
cell
interact
provid
opportun
therapeut
regard
betacoronavirus
replic
carri
transcript
activ
cell
cytosol
viral
genom
detect
like
receptor
rlr
helicas
upon
bind
vrna
rlr
activ
mitochondri
antivir
protein
mav
turn
trigger
phosphoryl
transcript
factor
gene
express
interferon
cytokin
pivot
effect
antivir
respons
mitochondri
function
thu
essenti
antivir
defens
organel
also
need
provid
increas
energet
need
infect
cell
fact
point
mitochondri
failur
mechan
unchain
sever
form
infect
brief
infect
cell
expos
overload
nascent
polypeptid
transcript
machineri
byproduct
helicas
activ
altogeth
jeopard
mainten
protein
fold
trigger
cell
mitochondri
stress
addit
genom
polyadelnyl
j
u
r
n
l
p
r
e
p
r
f
cytosol
could
wast
adenin
deposit
challeng
mitochondri
permeabl
transit
pore
mptp
ultim
mitochondri
proteostasi
collaps
would
drive
caspas
activ
irrevers
cell
damag
accord
avail
literatur
calcineurin
inhibitor
could
confer
protect
pathogen
process
briefli
compound
help
restor
unfoldedprotein
respons
upr
cytosol
may
way
rescu
cell
necrosi
addit
upon
target
cyclophilin
cyclosporin
inhibit
mptp
open
activ
mitochondri
upr
mtupr
prevent
mitochondri
failur
moreov
mechan
cyclosporin
shown
cardioprotect
effect
patient
myocardi
infarct
final
emphas
cyclosporin
shown
remark
antivir
activ
varieti
rna
virus
includ
famili
betacoronaviru
employ
cyclophilin
chaperon
nuclear
factor
activ
cell
nfat
major
signal
pathway
whole
suggest
deadli
action
host
cell
includ
pneumocyt
lymphocyt
result
failur
adapt
cell
mitochondri
stress
dysfunct
macrophag
remain
viru
reservoir
target
tissu
accord
model
cyclosporin
could
confer
protect
upstream
cytokin
storm
infect
patient
hypothesi
plan
test
random
clinic
trial
come
week
